Novavax CEO on the company's phase one Australia Covid-19 vaccine trial

Novavax will start human trials of Covid-19 vaccine in Australia. CNBC'S Kate Rogers speaks with Novavax CEO Stanley Erck about the company's decision to ramp up production early and their expectations for the trials.
Tue, May 26 202012:37 PM EDT